Current Cardiology Reviews

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Meta-Analysis

Safety and Efficacy of Zero Fluoroscopy Patent Ductus Arteriosus Closure in Comparison to the Standardized Fluoroscopy-Guided Procedure: A Systematic Review and Meta-Analysis

Author(s): Brian Mendel*orcid of author, Kelvin Kohar, Richie Jonathan Djiu, Defin Allevia Yumnanisha, Ananda Pipphali Vidya, Justin Winarta, Karunia Hafifah Arifin, Muhammad Dzaky Erlangga Mumtaz, Aqilla Katrita Zaira Nugroho, Gusti Ngurah Prana Jagannatha, Sisca Natalia Siagian and Radityo Prakoso

Volume 21, Issue 5, 2025

Published on: 31 January, 2025

Article ID: e1573403X338573 Pages: 9

DOI: 10.2174/011573403X338573241101092849

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Background: Patent Ductus Arteriosus (PDA) is a common condition in premature infants requiring intervention to avoid problems. Despite improvements in lowering radiation exposure and employing better contrast agents, fluoroscopy is still the most widely employed technique, which exposes interventional echocardiographers to radiation risks. Techniques, such as Transthoracic Echocardiography (TTE)-guided procedures or Transesophageal Echocardiography (TEE)-guided procedures, provide radiationfree options. This systematic review and meta-analysis aimed to evaluate the safety and effectiveness of fluoroscopy-guided versus non-fluoroscopy-guided PDA closure techniques with respect to the reduction in procedural risks and improved clinical decision-making when treating hemodynamically severe PDAs in premature newborns. As there is no specific age or cutoff for this procedure, it is crucial to perform it as early as possible to prevent complications, especially if symptoms are already present.

Methods: This systematic review has been registered in PROSPERO with registration number CRD42024516321. Three electronic databases (PubMed, Scopus, and Google Scholar) have been reviewed up to February 2024 to search the literature. The main outcome has been the procedural success rate. The additional outcomes have included procedural-related complications rate. We have performed a proportional meta-analysis using the random-effects model and the DerSimonian-Laird method. The risk of bias in all included studies has been evaluated using the STROBE guideline.

Results: A total of 85 (78 fluoroscopy and 7 zero-fluoroscopy) studies have been included in this study. Percutaneous PDA closure success rate has been significantly higher in zero-fluoroscopy group compared to fluoroscopy guidance [99.4% (95%CI: 98.1-100%) and 94.6% (95%CI: 92.3-97%, test for subgroup differences p < 0.01), respectively]. The complication rate has been similar in both groups [4% (95%CI: 0- 10%) in zero-fluoroscopy and 8.9% (95%CI: 6.5-11.3%) in fluoroscopy group, test for subgroup differences; p = 0.14]. Device embolization has been the most common complication reported in the fluoroscopy group [1.7% patients (95%CI: 1.1-2.3%)]. Meanwhile, the residual leak has been the only complication reported in the zero-fluoroscopy group [15.6% patients (95%CI: 0-37.5%)].

Conclusion: Patent Ductus Arteriosus (PDA) is common in preemies and requires intervention. While fluoroscopy is widely used with lower radiation and better contrast agents, it still carries radiation risks. Thus, this review has evaluated the safety and effectiveness of fluoroscopy versus zero-fluoroscopyguided PDA closures, aiming to reduce procedural risks and enhance clinical decisions for treating PDA.

Zero fluoroscopy techniques for percutaneous PDA closure have been found to yield comparable success rates and procedural outcomes to fluoroscopy-guided procedures. Considering its reduced side effects, zerofluoroscopy is safe and can be the preferred method to guide closures. However, future randomized controlled trials are necessary to better understand the exact role of interventional echocardiography in PDA closures.

Keywords: Echocardiography, PDA, percutaneous, TEE, TTE, zero-fluoroscopy.

Graphical Abstract

[1]
Picano E, Piccaluga E, Padovani R, Traino CA, Andreassi MG, Guagliumi G. Risks related to fluoroscopy radiation associated with electrophysiology procedures. J Atr Fibrillation 2014; 7(2): 1044.
[2]
Siagian SN, Prakoso R, Putra BE, et al. Echocardiography-guided percutaneous patent ductus arteriosus closure: 1-year single center experience in Indonesia. Front Cardiovasc Med 2022; 9: 885140.
[http://dx.doi.org/10.3389/fcvm.2022.885140] [PMID: 35677684]
[3]
Wang G, Wu Y, Pan Z, et al. Transesophageal echocardiography-guided percutaneous patent ductus arteriosus closure without fluoroscopy. J Cardiothorac Surg 2023; 18(1): 142.
[http://dx.doi.org/10.1186/s13019-023-02248-8] [PMID: 37060014]
[4]
Vanzant D, Mukhdomi J. Safety of Fluoroscopy in Patient, Operator, and Technician. In: StatPearls. Treasure Island (FL): StatPearls Publishing 2024.
[5]
Baruteau AE, Fraisse A, Butera G, Bautista-Rodriguez C. The transcatheter closure of patent ductus arteriosus in extremely low-birth-weight infants: Technique and results. J Cardiovasc Dev Dis 2023; 10(12): 476.
[http://dx.doi.org/10.3390/jcdd10120476] [PMID: 38132644]
[6]
Pan XB, Ouyang WB, Wang SZ, et al. Transthoracic echocardiography‐guided percutaneous patent ductus arteriosus occlusion: A new strategy for interventional treatment. Echocardiography 2016; 33(7): 1040-5.
[http://dx.doi.org/10.1111/echo.13207] [PMID: 27038152]
[7]
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.
[8]
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007; 370(9596): 1453-7.
[http://dx.doi.org/10.1016/S0140-6736(07)61602-X] [PMID: 18064739]
[9]
Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE. Patent ductus arteriosus: A contemporary perspective for the pediatric and adult cardiac care provider. J Am Heart Assoc 2022; 11(17): e025784.
[10]
Barcroft M, McKee C, Berman DP, et al. Percutaneous closure of patent ductus arteriosus. Clin Perinatol 2022; 49(1): 149-66.
[http://dx.doi.org/10.1016/j.clp.2021.11.009] [PMID: 35209997]
[11]
Baumgartner H, de Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021; 42(6): 563-645.
[12]
Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation 2019; 139(14): e698-800.
[PMID: 30586767]
[13]
Qian A, Jiang S, Gu X, et al. Treatment of patent ductus arteriosus and short-term outcomes among extremely preterm infants: A multicentre cohort study. EClinicalMedicine 2024; 67: 102356.
[http://dx.doi.org/10.1016/j.eclinm.2023.102356] [PMID: 38125962]
[14]
Baysson H, Nkoumazok B, Barnaoui S, et al. Follow-up of children exposed to ionising radiation from cardiac catheterisation: the Coccinelle study: Table 1. Radiat Prot Dosimetry 2015; 165(1-4): 13-6.
[http://dx.doi.org/10.1093/rpd/ncv039] [PMID: 25833897]
[15]
Prakoso R, Ariani R, Mendel B, Lilyasari O. Transoesophageal echocardiography-guided balloon-assisted percutaneous closure of a large secundum atrial septal defect in a pregnant woman: a case report. Eur Heart J Case Rep 2023; 8(1): ytae014.
[http://dx.doi.org/10.1093/ehjcr/ytae014] [PMID: 38274706]
[16]
Villemain O, Malekzadeh-Milani S, Sitefane F, Mostefa-Kara M, Boudjemline Y. Radiation exposure in transcatheter patent ductus arteriosus closure: time to tune? Cardiol Young 2018; 28(5): 653-60.
[http://dx.doi.org/10.1017/S1047951117002839] [PMID: 29347998]
[17]
Chen G, Wang Y, Proietti R, et al. Zero-fluoroscopy approach for ablation of supraventricular tachycardia using the Ensite NavX system: A multicenter experience. BMC Cardiovasc Disord 2020; 20(1): 48.
[http://dx.doi.org/10.1186/s12872-020-01344-0] [PMID: 32013865]
[18]
Mendel B, Faris Amin B, Prakoso R. Potency of non-fluoroscopy guided patent ductus arteriosus closure: A case report. SN Compr Clin Med 2021; 3(12): 2665-72.
[http://dx.doi.org/10.1007/s42399-021-01062-4]
[19]
Holzer RJ, Bergersen L, Thomson J, et al. PICS/AEPC/APPCS/CSANZ/SCAI/SOLACI: Expert consensus statement on cardiac catheterization for pediatric patients and adults with congenital heart disease. JACC Cardiovasc Interv 2024; 17(2): 115-216.
[http://dx.doi.org/10.1016/j.jcin.2023.11.001] [PMID: 38099915]
[20]
Venneri L, Rossi F, Botto N, et al. Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: Insights from the National Research Council’s Biological Effects of Ionizing Radiation VII Report. Am Heart J 2009; 157(1): 118-24.
[http://dx.doi.org/10.1016/j.ahj.2008.08.009] [PMID: 19081407]
[21]
McNamara DA, Chopra R, Decker JM, et al. Comparison of radiation exposure among interventional echocardiographers, interventional cardiologists, and sonographers during percutaneous structural heart interventions. JAMA Netw Open 2022; 5(7): e2220597.
[http://dx.doi.org/10.1001/jamanetworkopen.2022.20597] [PMID: 35797046]
[22]
Stahl CM, Meisinger QC, Andre MP, Kinney TB, Newton IG. Radiation risk to the fluoroscopy operator and staff. AJR Am J Roentgenol 2016; 207(4): 737-44.
[http://dx.doi.org/10.2214/AJR.16.16555] [PMID: 28829623]
[23]
Mettler FA Jr, Koenig TR, Wagner LK, Kelsey CA. Radiation injuries after fluoroscopic procedures. Semin Ultrasound CT MR 2002; 23(5): 428-42.
[http://dx.doi.org/10.1016/S0887-2171(02)90014-4] [PMID: 12509113]
[24]
Deraz S, Tawfik M, Kotit S, Elafifi A. Transcatheter device closure of patent ductus arteriosus by exclusive venous access under echocardiographic guidance without angiography. Cardiol Young 2022; 32(1): 55-9.
[http://dx.doi.org/10.1017/S104795112100158X] [PMID: 33896438]
[25]
Wang C, Zhang F, Ouyang W, Zhao G, Lu W, Zou M. Transcatheter closure of patent ductus arteriosus under echocardiography guidance: A randomized controlled noninferiority trial. J Interv Cardiol 2020; 2020: 4357017.
[26]
Siagian SN, Prakoso R, Mendel B, et al. Transesophageal echocardiography-guided percutaneous closure of multiple muscular ventricular septal defects with pulmonary hypertension using single device: A case report. Front Cardiovasc Med 2023; 10: 1093563.
[http://dx.doi.org/10.3389/fcvm.2023.1093563] [PMID: 37034333]
[27]
Raja Shariff RE, Soesanto AM, Scalia GM, Ewe SH, Izumo M, Liu L. Echocardiographic Imaging in Transcatheter Structural Intervention: An AAE Review Paper. JACC Asia 2023; 3(4): 556-79.
[28]
Barker TH, Migliavaca CB, Stein C, et al. Conducting proportional meta-analysis in different types of systematic reviews: A guide for synthesisers of evidence. BMC Med Res Methodol 2021; 21(1): 189.
[http://dx.doi.org/10.1186/s12874-021-01381-z] [PMID: 34544368]

Rights & Permissions Print Cite